Viewing Study NCT01955460


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-27 @ 11:45 PM
Study NCT ID: NCT01955460
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-14
First Post: 2013-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module